CannabisNewsBreaks

TuesdayJun 20, 2017 9:29 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Secures Funding to Drive Development of Bitcoin Payment Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has successfully closed a $1 million company-friendly convertible promissory note with an institutional investor. Per the update, the company intends to use this funding to execute on its previously announced bitcoin payments solution, which it is developing in partnership with First BitCoin Capital (OTC: BITCF). “This is great timing for SinglePoint. We have many acquisitions deals in the pipeline, and access to this capital will exponentially increase the chances of getting these done,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “In addition, we have many…

Continue Reading

ThursdayJun 15, 2017 3:52 pm

CannabisNewsBreaks – MYM Nutraceuticals, Inc. (MYMMF) Appoints New Executive Chairman; Details Insider Share Purchases

MYM Nutraceuticals (CSE: MYM) (OTC: MYMMF) earlier this month appointed Erick Factor to the company’s board of directors and as executive chairman. As the founder of Vancouver-based “Westcoast Medicann” dispensary, Factor has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and he has provided medical marijuana to thousands of patients over the past two decades. Additionally, the company released a list of company insiders who bought shares in the last private placement at $0.18; total proceeds from insider share purchases totaled $343,137.96. To view the full press release, visit: http://nnw.fm/e8PuU About MYM MYM Nutraceuticals Inc. (CSE:MYM)…

Continue Reading

ThursdayJun 15, 2017 12:15 pm

CannabisNewsBreaks – SinglePoint’s (SING) Bitcoin Solution Could Make Marijuana Industry’s Banking Problems a Thing of the Past

Marijuana has now been legalized in some form in 29 states and in the District of Columbia, yet marijuana dispensaries and other cannabis-related businesses lack access to banking options, forcing them to conduct cash only transactions. SinglePoint, Inc. (OTC: SING) may at last have found the answer for these currently “unbankable” businesses by developing a bitcoin payment solution that would enable cannabis users to purchase marijuana products using debit or credit cards. “The company’s SingleSeed subsidiary is already engaged in offering mobile marketing and payment solutions to businesses in the marijuana industry, including cashless ATM, Pay-by-Text™ and text message marketing.…

Continue Reading

ThursdayJun 15, 2017 8:51 am

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Bolsters Leadership Team through Addition of Nevada Assistant Controller Geoffrey Lawrence as CFO, CCO

Player’s Network, Inc. (OTCQB: PNTV) this morning announced its appointment of Nevada Assistant Controller Geoffrey Lawrence as the company’s chief financial officer and chief compliance officer, effective July 1, 2017. “Geoffrey is a senior-level operator who will help us fulfill our commitment to our shareholders and the investment community insofar as our goals of increased transparency and stronger corporate governance,” Mark Bradley, CEO of PNTV, stated in the news release. “As PNTV continues to grow its assets, it is necessary that we assemble a strong first-class management team, and Geoffrey is a perfect fit, bringing to the table the necessary…

Continue Reading

WednesdayJun 14, 2017 10:55 am

CannabisNewsBreaks – Research Report Highlights Hefty Market Potential for ChineseInvestors.com, Inc. (CIIX)

ChineseInvestors.com, Inc. (OTCQB: CIIX), which recently took part in SeeThruEquity’s 6th Annual Microcap Investor Conference in early June, offers educational consulting services for Chinese investors and is also pursuing opportunities in the cannabis market.  SeeThruEquity recently increased the price target on CIIX to $3.75 from $2.05, and predicted that revenues from the company’s hemp business could reach 8-digit sales by 2020. “The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in…

Continue Reading

WednesdayJun 14, 2017 9:25 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 9:00 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading

MondayJun 12, 2017 8:55 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’. If the patent filing is granted and proven, IGC anticipates that it could create a “significant therapeutic pathway” in the Alzheimer’s disease market, which is expected to record direct costs in excess of $450 billion annually in the next 12 years. “Securing this…

Continue Reading

WednesdayJun 07, 2017 3:13 pm

CannabisNewsBreaks – Player’s Network (PNTV) Shares Continue Two-Day Streak, Set Second New High this Week

Shares of Player’s Network (OTCQB: PNTV) are up 7% at $0.10 near market close, moving on volume of 5.83 million and setting a new 52-week high for the third time since last Friday. On June 2, PNTV announced (http://nnw.fm/2s34T) that its majority owned Green Leaf Farms subsidiary had completed the first phase of construction for its marijuana cultivation and production facility in North Las Vegas. This achievement was preceded by news earlier in the week that Green Leaf received two Nevada state-issued recreational marijuana licenses, as well as medical marijuana licenses (http://nnw.fm/9XLst). PNTV said the licenses create another revenue stream…

Continue Reading

WednesdayJun 07, 2017 10:15 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor

India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company looks forward to Dr. Cheifetz’s contributions as IGC moves forward in the development of unique cannabis combination therapies. “The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for…

Continue Reading